Project Grant DP2MH136588
Award Date
9/1/23
Completion Date
8/31/26
Dollars Obligated
$1.4M
Funding Federal Agency
Office of the Director
Awarding Federal Agency
National Institute of Mental Health
Federal Grant Program
93.310
Assistance Type
Project Grant
Place of Performance
Davis, CA, USA
Similar Awards
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372), provides $1,124,850 to the University of California, San Diego (UCSD) to develop "photocaged DREADD agonists" - genetically-encoded tools that allow researchers to optically control neural activity in specific cell types. The goal is to create an improved...
This Project Grant award of $811,112 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research on the neural mechanisms underlying sudden insight learning of cue-reward associations. The University of California, San Francisco (UCSF) will conduct this 5-year research project to investigate the network and circuit dynamics in brain regions such as lateral entorhinal cortex, hippocampal CA1, and orbitofrontal cortex that...
This Project Grant from the National Institutes of Health's National Institute of Mental Health, under the Mental Health Research Grants program (CFDA 93.242), provides $4,819,656 to The Johns Hopkins University to develop new fluorescent protein-based kinase biosensors for multiplex neuronal imaging of signaling pathways in behaving mice. The goal is to simultaneously monitor the activity of signaling pathways involved in synaptic plasticity, such as PKA, CaMKII, ERK, and PKC, and to use in...
The University of California, San Diego will receive $3,868,694 under a three-year Project Grant from the National Institute on Aging, part of the National Institutes of Health, to develop selective amyloid-responsive fluorescent probes. The goal is to uncover design principles for probes that can selectively detect aggregated forms of alpha-synuclein or tau versus amyloid-beta in solution and tissue. The university will also develop a method to characterize the distribution of amyloidogenic...
This Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) provides $222,254 to the University of California, Irvine to examine the effects of psychedelic 5-HT2A agonist drugs, DOI and psilocybin, on aberrant reward-seeking behavior in an established rat model of early-life adversity. The goal is to determine the effective dose range of these psychedelic drugs and investigate their ability to reverse anhedonia (reduced pleasure...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $477,000.00 to the University of California, San Diego (UCSD) to conduct research on the organization of secretory compartments in neurons. The key objectives are to use cryo-correlative light and electron microscopy, cryo-focused ion beam milling, and cryo-electron tomography to dissect the molecular architecture of the dendritic and...
This three-year, $2.288 million project grant from the National Institutes of Health's National Institute on Drug Abuse will support the development of new analytic tools and computational frameworks to understand complex spatiotemporal brain activity from large-scale, multi-modal neuroscience data. Specifically, the New York University School of Medicine will utilize electrophysiological recordings and calcium imaging data to decode representations of spatial and task information in hippocampal...
The National Institute of Mental Health (NIMH) awarded a $679,118 Project Grant (CFDA 93.242 - Mental Health Research Grants) to the University of California, Santa Cruz (UCSC) to study the cellular and circuit mechanisms underlying the long-lasting therapeutic effects of the psychedelic drug psilocybin in the stressed brain. The project aims to determine how psilocybin affects synaptic plasticity, cortical functional networks, and the representation of behavioral variables in the stressed...
The National Institutes of Health (NIH) Office of the Director awarded a $1,345,424 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to the Regents of the University of Michigan. The grant, effective September 10, 2024 through September 9, 2027, aims to develop a novel genetically encoded "protein ticker tape" system that enables long-term, brain-wide recording of single-cell physiology in live mice without external interfacing. The technology will leverage...
The University of California, Davis received a $201,250 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The award, with a project period from September 1, 2024 to August 31, 2026, will support the development of a nanobody toolkit to study connexin channels, which are crucial for intercellular communication during development and physiology. The research aims to increase understanding...